Cargando…

Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23

AIMS: To investigate the effects and underlying mechanism of dexmedetomidine on the cultured human dendritic cells (DCs). METHODS: Human DCs and cytotoxic T lymphocytes (CTLs) were obtained from human cord blood mononuclear cells by density gradient centrifugation. Cultured DCs were divided into thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gong, Le, Yuan, Zhou, Lei, Gong, Li, Li, Xiaoxiao, Li, Yunli, Liao, Qin, Duan, Kaiming, Tong, Jianbin, Ouyang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824534/
https://www.ncbi.nlm.nih.gov/pubmed/27054340
http://dx.doi.org/10.1371/journal.pone.0153288
_version_ 1782426112950796288
author Chen, Gong
Le, Yuan
Zhou, Lei
Gong, Li
Li, Xiaoxiao
Li, Yunli
Liao, Qin
Duan, Kaiming
Tong, Jianbin
Ouyang, Wen
author_facet Chen, Gong
Le, Yuan
Zhou, Lei
Gong, Li
Li, Xiaoxiao
Li, Yunli
Liao, Qin
Duan, Kaiming
Tong, Jianbin
Ouyang, Wen
author_sort Chen, Gong
collection PubMed
description AIMS: To investigate the effects and underlying mechanism of dexmedetomidine on the cultured human dendritic cells (DCs). METHODS: Human DCs and cytotoxic T lymphocytes (CTLs) were obtained from human cord blood mononuclear cells by density gradient centrifugation. Cultured DCs were divided into three groups: dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group and control group. DCs in the three groups were treated with dexmedetomidine, dexmedetomidine plus yohimbine and culture medium, respectively. After washing, the DCs were co-incubated with cultured CTLs. The maturation degree of DCs was evaluated by detecting (1) the ratios of HLA-DR-, CD86-, and CD80-positive cells (flow cytometry), and (2) expression of IL-12 and IL-23 (PCR and Elisa). The function of DCs was evaluated by detecting the proliferation (MTS assay) and cytotoxicity activity (the Elisa of IFN-γ) of CTLs. In addition, in order to explore the mechanisms of dexmedetomidine modulating DCs, α2-adrenergic receptor and its downstream signals in DCs were also detected. RESULTS: The ratios of HLA-DR-, CD86-, and CD80-positive cells to total cells were similar among the three groups (P>0.05). Compared to the control group, the protein levels of IL-12 and IL-23 in the culture medium and the mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the DCs all decreased in dexmedetomidine group (P<0.05). In addition, the proliferation of CTLs and the secretion of IFN-γ also decreased in the dexmedetomidine group, compared with the control group (P<0.05). Moreover, these changes induced by dexmedetomidine in the dexmedetomidine group were reversed by α2-adrenergic receptor inhibitor yohimbine in the dexmedetomidine plus yohimbine group. It was also found the decrease of mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the dexmedetomidine group could be reversed by ERK1/2 or AKT inhibitors. CONCLUSION: Dexmedetomidine could negatively modulate human immunity by inhibiting the maturation of DCs and then decreasing the proliferation and cytotoxicity activity of CTLs. The α2-adrenergic receptors and its downstream molecules ERK1/2 and AKT are closely involved in the modulation of dexmedetomidine on DCs.
format Online
Article
Text
id pubmed-4824534
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48245342016-04-22 Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23 Chen, Gong Le, Yuan Zhou, Lei Gong, Li Li, Xiaoxiao Li, Yunli Liao, Qin Duan, Kaiming Tong, Jianbin Ouyang, Wen PLoS One Research Article AIMS: To investigate the effects and underlying mechanism of dexmedetomidine on the cultured human dendritic cells (DCs). METHODS: Human DCs and cytotoxic T lymphocytes (CTLs) were obtained from human cord blood mononuclear cells by density gradient centrifugation. Cultured DCs were divided into three groups: dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group and control group. DCs in the three groups were treated with dexmedetomidine, dexmedetomidine plus yohimbine and culture medium, respectively. After washing, the DCs were co-incubated with cultured CTLs. The maturation degree of DCs was evaluated by detecting (1) the ratios of HLA-DR-, CD86-, and CD80-positive cells (flow cytometry), and (2) expression of IL-12 and IL-23 (PCR and Elisa). The function of DCs was evaluated by detecting the proliferation (MTS assay) and cytotoxicity activity (the Elisa of IFN-γ) of CTLs. In addition, in order to explore the mechanisms of dexmedetomidine modulating DCs, α2-adrenergic receptor and its downstream signals in DCs were also detected. RESULTS: The ratios of HLA-DR-, CD86-, and CD80-positive cells to total cells were similar among the three groups (P>0.05). Compared to the control group, the protein levels of IL-12 and IL-23 in the culture medium and the mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the DCs all decreased in dexmedetomidine group (P<0.05). In addition, the proliferation of CTLs and the secretion of IFN-γ also decreased in the dexmedetomidine group, compared with the control group (P<0.05). Moreover, these changes induced by dexmedetomidine in the dexmedetomidine group were reversed by α2-adrenergic receptor inhibitor yohimbine in the dexmedetomidine plus yohimbine group. It was also found the decrease of mRNA levels of IL-12 p35, IL-12 p40 and IL-23 p19 in the dexmedetomidine group could be reversed by ERK1/2 or AKT inhibitors. CONCLUSION: Dexmedetomidine could negatively modulate human immunity by inhibiting the maturation of DCs and then decreasing the proliferation and cytotoxicity activity of CTLs. The α2-adrenergic receptors and its downstream molecules ERK1/2 and AKT are closely involved in the modulation of dexmedetomidine on DCs. Public Library of Science 2016-04-07 /pmc/articles/PMC4824534/ /pubmed/27054340 http://dx.doi.org/10.1371/journal.pone.0153288 Text en © 2016 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Gong
Le, Yuan
Zhou, Lei
Gong, Li
Li, Xiaoxiao
Li, Yunli
Liao, Qin
Duan, Kaiming
Tong, Jianbin
Ouyang, Wen
Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23
title Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23
title_full Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23
title_fullStr Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23
title_full_unstemmed Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23
title_short Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23
title_sort dexmedetomidine inhibits maturation and function of human cord blood-derived dendritic cells by interfering with synthesis and secretion of il-12 and il-23
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824534/
https://www.ncbi.nlm.nih.gov/pubmed/27054340
http://dx.doi.org/10.1371/journal.pone.0153288
work_keys_str_mv AT chengong dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT leyuan dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT zhoulei dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT gongli dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT lixiaoxiao dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT liyunli dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT liaoqin dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT duankaiming dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT tongjianbin dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23
AT ouyangwen dexmedetomidineinhibitsmaturationandfunctionofhumancordbloodderiveddendriticcellsbyinterferingwithsynthesisandsecretionofil12andil23